FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3091751803> ?p ?o ?g. }

• W3091751803 endingPage "573" @default.
• W3091751803 startingPage "573" @default.
• W3091751803 abstract "Applied research is crucial in pushing the boundaries and finding a solution to the age-old problem of dog-mediated rabies. Although oral vaccination of dogs is considered to have great potential in mass dog vaccination campaigns and could have far-reaching benefits, it is perhaps the most ignored of all available tools in efforts to eliminate dog-mediated rabies, not least because of limited data on immunogenicity, efficacy, and safety of potential oral rabies vaccine candidates. In this study, the long-term immunogenicity in local Thai dogs after oral administration of the highly attenuated 3rd generation rabies virus vaccine strain SPBN GASGAS was assessed. The oral rabies vaccine was administered to dogs by either direct oral administration (n = 10) or by offering a vaccine loaded intestine bait (n = 15). The humoral immune response was then compared to three groups of dogs; a group that received a parenteral delivered inactivated rabies vaccine (n = 10), a group offered a placebo intestine bait (n = 7), and a control group (n = 4) for an observation period of 365 days. There was no significant difference in the immune response of dogs that received oral and parenteral vaccine in terms of magnitude, kinetics, and persistence of both rabies virus (RABV) neutralizing (RFFIT) and binding (ELISA) antibodies. Although the single parenteral injection of an inactivated rabies vaccine mounted a slightly higher humoral immune response than the orally delivered live vaccine, RABV specific antibodies of both types were still detectable after one year in most animals for all treatment groups and resulted in no difference in seropositivity. Characterization of rabies specific antibodies revealed two main classes of antibodies involved in the immune response of dogs vaccinated. While IgM antibodies were the first to appear, the succeeding IgG response was mainly IgG2 dominated independent of the vaccine type used. The results support the view that SPBN GASGAS induces a sustained detectable immune response in local dogs both after direct oral administration and via bait application." @default.
• W3091751803 created "2020-10-08" @default.
• W3091751803 creator A5015038856 @default.
• W3091751803 creator A5024008320 @default.
• W3091751803 creator A5026559156 @default.
• W3091751803 creator A5026804439 @default.
• W3091751803 creator A5032832568 @default.
• W3091751803 creator A5033955963 @default.
• W3091751803 creator A5043106435 @default.
• W3091751803 creator A5057418301 @default.
• W3091751803 creator A5058221430 @default.
• W3091751803 creator A5062540157 @default.
• W3091751803 creator A5063665356 @default.
• W3091751803 creator A5065219839 @default.
• W3091751803 date "2020-10-01" @default.
• W3091751803 modified "2023-10-09" @default.
• W3091751803 title "Humoral Immune Response of Thai Dogs after Oral Vaccination against Rabies with the SPBN GASGAS Vaccine Strain" @default.
• W3091751803 cites W1983800133 @default.
• W3091751803 cites W2015350167 @default.
• W3091751803 cites W2021004670 @default.
• W3091751803 cites W2041321092 @default.
• W3091751803 cites W2065928396 @default.
• W3091751803 cites W2073034493 @default.
• W3091751803 cites W2094406945 @default.
• W3091751803 cites W2096365655 @default.
• W3091751803 cites W2120934662 @default.
• W3091751803 cites W2123086290 @default.
• W3091751803 cites W2156510703 @default.
• W3091751803 cites W2158827389 @default.
• W3091751803 cites W2169656611 @default.
• W3091751803 cites W2186661429 @default.
• W3091751803 cites W2402357695 @default.
• W3091751803 cites W2405468348 @default.
• W3091751803 cites W2586765610 @default.
• W3091751803 cites W2625954032 @default.
• W3091751803 cites W2712323394 @default.
• W3091751803 cites W2738063180 @default.
• W3091751803 cites W2765388138 @default.
• W3091751803 cites W2766817698 @default.
• W3091751803 cites W2800446598 @default.
• W3091751803 cites W2803576029 @default.
• W3091751803 cites W2808339545 @default.
• W3091751803 cites W2883074081 @default.
• W3091751803 cites W2913347098 @default.
• W3091751803 cites W2918888992 @default.
• W3091751803 cites W2942920107 @default.
• W3091751803 cites W2957202489 @default.
• W3091751803 cites W2966841612 @default.
• W3091751803 cites W2970412018 @default.
• W3091751803 cites W2971383594 @default.
• W3091751803 cites W3007965558 @default.
• W3091751803 cites W3008843671 @default.
• W3091751803 cites W3012820189 @default.
• W3091751803 cites W3038278797 @default.
• W3091751803 cites W4230939395 @default.
• W3091751803 doi "https://doi.org/10.3390/vaccines8040573" @default.
• W3091751803 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7711832" @default.
• W3091751803 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33019605" @default.
• W3091751803 hasPublicationYear "2020" @default.
• W3091751803 type Work @default.
• W3091751803 sameAs 3091751803 @default.
• W3091751803 citedByCount "17" @default.
• W3091751803 countsByYear W30917518032021 @default.
• W3091751803 countsByYear W30917518032022 @default.
• W3091751803 countsByYear W30917518032023 @default.
• W3091751803 crossrefType "journal-article" @default.
• W3091751803 hasAuthorship W3091751803A5015038856 @default.
• W3091751803 hasAuthorship W3091751803A5024008320 @default.
• W3091751803 hasAuthorship W3091751803A5026559156 @default.
• W3091751803 hasAuthorship W3091751803A5026804439 @default.
• W3091751803 hasAuthorship W3091751803A5032832568 @default.
• W3091751803 hasAuthorship W3091751803A5033955963 @default.
• W3091751803 hasAuthorship W3091751803A5043106435 @default.
• W3091751803 hasAuthorship W3091751803A5057418301 @default.
• W3091751803 hasAuthorship W3091751803A5058221430 @default.
• W3091751803 hasAuthorship W3091751803A5062540157 @default.
• W3091751803 hasAuthorship W3091751803A5063665356 @default.
• W3091751803 hasAuthorship W3091751803A5065219839 @default.
• W3091751803 hasBestOaLocation W30917518031 @default.
• W3091751803 hasConcept C109663412 @default.
• W3091751803 hasConcept C126322002 @default.
• W3091751803 hasConcept C159047783 @default.
• W3091751803 hasConcept C159654299 @default.
• W3091751803 hasConcept C203014093 @default.
• W3091751803 hasConcept C22070199 @default.
• W3091751803 hasConcept C2776849203 @default.
• W3091751803 hasConcept C2777056448 @default.
• W3091751803 hasConcept C2777961786 @default.
• W3091751803 hasConcept C2780674857 @default.
• W3091751803 hasConcept C2780868878 @default.
• W3091751803 hasConcept C71924100 @default.
• W3091751803 hasConcept C8891405 @default.
• W3091751803 hasConceptScore W3091751803C109663412 @default.
• W3091751803 hasConceptScore W3091751803C126322002 @default.
• W3091751803 hasConceptScore W3091751803C159047783 @default.
• W3091751803 hasConceptScore W3091751803C159654299 @default.
• W3091751803 hasConceptScore W3091751803C203014093 @default.
• W3091751803 hasConceptScore W3091751803C22070199 @default.

• next